Follow

"In the current study, we compared three different formulations for saRNA, a cationic polymer (pABOL12), a lipid emulsion (nanostructured lipid carrier, NLC13), and three lipid nanoparticles (LNPs). We investigated the early inflammatory profile after immunization and explored how that related to downstream adaptive immune responses. We then explored the role of RNA sensing on the adaptive immune response to vaccination."

cell.com/molecular-therapy-fam

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.